Canaccord Constructive on Intellia Therapeutics (NTLA), 'Key programs continue to progress on track'
Tweet Send to a Friend
(Updated - February 23, 2024 9:23 AM EST)
Canaccord Genuity analyst Whitney Ijem raised the price target on Intellia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney Ijem raised the price target on Intellia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
